Annual Working Capital
$96.46 M
+$5.03 M+5.50%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual working capital is $96.46 million, with the most recent change of +$5.03 million (+5.50%) on December 31, 2023.
- During the last 3 years, ANTX annual working capital has risen by +$93.69 million (+3376.18%).
- ANTX annual working capital is now at all-time high.
Performance
ANTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$87.67 M
-$9.64 M-9.91%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly working capital is $87.67 million, with the most recent change of -$9.64 million (-9.91%) on September 30, 2024.
- Over the past year, ANTX quarterly working capital has dropped by -$17.98 million (-17.02%).
- ANTX quarterly working capital is now -23.56% below its all-time high of $114.70 million, reached on March 31, 2022.
Performance
ANTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ANTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | -17.0% |
| 3 y3 years | +3376.2% | -17.0% |
| 5 y5 years | +3376.2% | -17.0% |
ANTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.1% | -23.6% | +54.6% |
| 5 y | 5-year | at high | +3376.2% | -23.6% | +54.6% |
| alltime | all time | at high | +3376.2% | -23.6% | +54.6% |
AN2 Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $87.67 M(-9.9%) |
| Jun 2024 | - | $97.31 M(-7.9%) |
| Mar 2024 | - | $105.65 M(+9.5%) |
| Dec 2023 | $96.46 M(+5.5%) | $96.46 M(-13.5%) |
| Sep 2023 | - | $111.57 M(+28.2%) |
| Jun 2023 | - | $87.05 M(+6.5%) |
| Mar 2023 | - | $81.75 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $91.44 M(+61.2%) | $91.44 M(-11.1%) |
| Sep 2022 | - | $102.86 M(-8.8%) |
| Jun 2022 | - | $112.73 M(-1.7%) |
| Mar 2022 | - | $114.70 M(+102.2%) |
| Dec 2021 | $56.71 M(+1943.6%) | - |
| Dec 2021 | - | $56.71 M |
| Dec 2020 | $2.77 M | - |
FAQ
- What is AN2 Therapeutics annual working capital?
- What is the all time high annual working capital for AN2 Therapeutics?
- What is AN2 Therapeutics annual working capital year-on-year change?
- What is AN2 Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly working capital year-on-year change?
What is AN2 Therapeutics annual working capital?
The current annual working capital of ANTX is $96.46 M
What is the all time high annual working capital for AN2 Therapeutics?
AN2 Therapeutics all-time high annual working capital is $96.46 M
What is AN2 Therapeutics annual working capital year-on-year change?
Over the past year, ANTX annual working capital has changed by +$5.03 M (+5.50%)
What is AN2 Therapeutics quarterly working capital?
The current quarterly working capital of ANTX is $87.67 M
What is the all time high quarterly working capital for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly working capital is $114.70 M
What is AN2 Therapeutics quarterly working capital year-on-year change?
Over the past year, ANTX quarterly working capital has changed by -$17.98 M (-17.02%)